Tyra Biosciences, Inc. · NASDAQ:TYRA
BVF PARTNERS L P/IL reported a 7.80% stake in Tyra Biosciences, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
BVF PARTNERS L P/IL reported a 7.80% stake in Tyra Biosciences, Inc., 3,944,194 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 7.80%
- Shares
- 3,944,194
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 10 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 4.00% | 2,032,310 |
| BVF I GP LLC | 4.00% | 2,032,310 |
| BIOTECHNOLOGY VALUE FUND II LP | 3.20% | 1,642,427 |
| BVF II GP LLC | 3.20% | 1,642,427 |
| Biotechnology Value Trading Fund OS LP | 0.40% | 205,920 |
| BVF Partners OS Ltd. | 0.40% | 205,920 |
| BVF GP HOLDINGS LLC | 7.30% | 3,674,737 |
| BVF PARTNERS L P/IL | 7.80% | 3,944,194 |
| BVF INC/IL | 7.80% | 3,944,194 |
| LAMPERT MARK N | 7.80% | 3,944,194 |
Source
Related
- Tyra Biosciences, Inc.
- Bvf Partners L P
- Tyra Biosciences, Inc. shareholders
- Schedule 13G · Bvf Partners L P · Sep 21, 2026
- Schedule 13G/A · Bvf Partners L P · Feb 17, 2026
- Form 4 · Harris Todd · Sep 17, 2026
- Form 4 · Rueb Yuliya · Sep 17, 2026
- Form 4 · Fuhrman Alan · Sep 17, 2026
- Schedule 13D/A · Ra Capital Management, L.P. · Sep 17, 2026
- Schedule 13G · Paradigm Biocapital Advisors LP · Sep 17, 2026